title: Beta-blocker supplementation of standard drug treatment for schizophrenia.
authors: Institute of Clinical Research India, 242A, 13th Cross, CMH Road, 560038 Bangalore, Karnataka, India. elenashek@yahoo.co.uk
authors: Elena
authors: E
authors: Shek
authors: Sabyasachi
authors: S
authors: Bardhan
authors: Maxim V
authors: MV
authors: Cheine
authors: Juha
authors: J
authors: Ahonen
authors: Kristian
authors: K
authors: Wahlbeck
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents